News

Startups Meet Pharma

…a challenge-based acceleration Programme for Startups and Key Pharma Companies in Europe.

The EIT Health Startups Meet Pharma is a challenge-based acceleration programme connecting startups developing innovative solutions for chronic care with key pharma partners in Europe. The programme invites startups developing solutions which impact both the Pharma industry and patients, to tackle set challenges in collaboration with top pharma partners.

The programme had its premiere in 2019 with 14 healthcare startups from all over Europe that tackled five different challenges set up by EIT Health Partners Amgen, Bayer, Ferrer, Janssen and UCB. Read more about the 2019 edition.

 

Startups Meet Pharma 2020 call is officially open!

The programme 

The programme targets start-ups with already functioning product/prototype that already entered the market/are about to enter the market. Selection of companies is based on the quality of the business idea, their fit for the selected challenge and the team’s motivation and level of commitment. Please note that only incorporated companies may apply to the programme.

The selected startups will receive a grant to cover travel and accommodation costs and mentoring services through the Mentoring and Coaching Network Platform.

Challenges for 2020

In 2020, five challenges have been released in collaboration with four EIT Health Partners: Amgen, Bayer, Beiersdorf and Boehringer Ingelheim. 

 

Title: Encourage continuity in treatment strategy and  treatment optimisation for post-myocardial infarction patients

Looking for: A solution which will create a standardised procedure for post MI patients after discharge

 

Title: Choosing the right treatment for Multiple Myeloma patients

Looking for: Creation of an algorithm, that would help physicians choosing the right treatment for Multiple Myeloma patients

 

Title: Disruptive Gene therapies, cell therapies and delivery technologies for different therapeutic areas

Looking for: Disruptive technologies useful in the therapeutic areas of Cardiology, Oncology, Gynecology, Ophthalmology, Hematology and Women’s Health – or ideally for all of those as a platform technology. Breakthrough innovations for other or multiple indications might be of interest as well.

 

 

Title: Improving the condition of diabetic skin

Looking for: BioTech, MedTech or Digital Health solutions to improve the condition of diabetic skin

 

Title: Portable Interstitial Lung Disease (ILD) Diagnostic Tool

Looking for: A solution which could potentially help a wider range of Healthcare Professionals to early diagnose ILDs.

 

The detailed description of the five challenges can be found here

 

Program structure

The program consists of four different modules with the objective to train and prepare startups to discuss collaboration opportunities with pharma companies.

  • Module 1 (June 15-19, Heidelberg) : 5 days “Innovation & Entrepreneurship training”. Startups will receive tailored workshops by pharma experts on the different tools and methods to successfully build their business.
  • Module 2 (29 June – 3 July in Heidelberg) : 5 days workshops by pharma partners involved in the program on how to collaborate with big players in the market.
  • Module 3 (September 2020) : Startups will visit selected pharma companies involved in the program to discuss collaboration opportunities.
  • Module 4 (November 2020 – date & location TBD) : Demo Day. Startups will pitch their achievements in front of Investors and EIT Health stakeholders.

Application period: 10 February – 30 March 2020, through the EIT Health Optimy platform

If you have any questions regarding the programme, EIT Health Germany is organising two webinars in March 2020.

 

Contact Information: 

Barbara Costa ( barbara.costa@eithealth.eu )

Matteo Consonni ( matteo.consonni@eithealth.eu )

 

Gold sponsors                                                      Silver sponsor